Verastem Oncology annonce l'acceptation par la FDA et l'examen prioritaire de la demande de nouveau médicament pour l'avutométinib en association avec le défactinib pour le traitement du cancer de l'ovaire séreux de bas grade récurrent mutant KRAS.
Verastem Oncology annonce l'acceptation par la FDA et l'exame…
Dec 30, 2024
zonebourse.com
Interpreting Results From RAMP 201: Avutometinib /- Defactinib in Recurrent LGSOC | OncLive
Interpreting Results From RAMP 201: Avutometinib /- Defactinib in …
Nov 3, 2023
onclive.com
Dr Monk on Avutometinib Plus Defactinib in Low-Grade Serous Ovarian Cancer | OncLive
Dr Monk on Avutometinib Plus Defactinib in Low-Grade Serous O…
1 week ago
onclive.com
Verastem Oncology provides update on Ramp 203 phase 1/2 clinical trial
Verastem Oncology provides update on Ramp 203 phase 1/2 clinical trial
1 month ago
marketscreener.com
Verastem Oncology publie de nouvelles données positives sur l'étude de phase 1/2 de GenFleet Therapeutics en Chine pour le GFH375 (VS-7375) dans l'adénocarcinome canalaire pancréatique mutant KRAS G12D
Verastem Oncology publie de nouvelles données positives sur l'…
4 months ago
zonebourse.com
Research | Verastem, Inc.
Research | Verastem, Inc.
11 months ago
verastem.com
Verastem Oncology and STAAR Ovarian Cancer Foundation Establish the Inaugural Low-Grade Serous Ovarian Cancer (LGSOC) Awareness Day on September 9, 2024
Verastem Oncology and STAAR Ovarian Cancer Foundation Establ…
Sep 3, 2024
financialpost.com
Verastem Oncology announces transition plan to accelerate next …
2 months ago
marketscreener.com
2:04
FDA Approves First Gene Therapy To Successfully Treat Cancer | NB…
28K viewsJul 12, 2017
YouTubeNBC News
0:11
The World Ovarian Cancer Coalition is grateful to partners like Veraste…
41 views2 weeks ago
FacebookWorld Ovarian Cancer Coalition
Pipeline | Verastem, Inc.
2 weeks ago
verastem.com
1:34
Exclusive Interview with Dr. Jonathan Pachter, Chief Scientific …
67 views7 months ago
YouTubeGeneOnline 基因線上
14:51
FDA Approves the AVMAPKI™ FAKZYNJA™ Combination Therap…
9 months ago
YahooBusiness Wire
9:03
Low-Grade Serous Ovarian Cancer
6.1K viewsDec 2, 2019
YouTubeOncLive
1:38:34
KRAS Cancer Clinical Trial Updates: What Patients Need to Know from …
27.9K views8 months ago
YouTubeKRAS Cancer Kickers
41:31
Evolving strategies in low-grade serous ovarian cancer: Applying t…
44 views1 month ago
YouTubeTouch Medical Media
Vstm Stock Quote: Verastem's Rise in Cancer-Focused Trading
5 months ago
cgaa.org
1:48
FAK Inhibitors Market Outlook | Emerging Cancer Therapies, Mark…
3 views1 month ago
YouTubeDelveInsight Business Research
Hedge Funds Never Loved Verastem Inc (VSTM) More
Jun 24, 2020
insidermonkey.com
21:15
Clinical Trials for Pancreatic Cancer
2.1K views5 months ago
YouTubeLet's Win Pancreatic Cancer
35:02
Inside Cancer Innovation Radiopharm ASX RAD Shares Wh…
182 views5 months ago
YouTubeKalkine Media
Verastem (NASDAQ:VSTM) shareholders have endured a 62% …
Aug 12, 2022
nasdaq.com
1:02
This Gynaecological Cancer Awareness Month, we’re highlighti…
318 views5 months ago
FacebookThe Institute of Cancer Research
1:15
Doc Talk: Premal Thaker, MD, MS on Low-Grade Serous Ovarian Cance…
57 viewsOct 13, 2023
YouTubeLet's Talk About LGSOC
6:10
Ras Raf MEK ERK Signaling Pathway - Overview, Regulation a…
1.9K viewsNov 30, 2019
bilibilitggtgg
1:36
Efficiency Meets Care: Transforming Healthcare with Veradigm
53.6K viewsNov 22, 2023
YouTubeVeradigm®
1:47
Patient Testimonials: Low-Grade Serous Ovarian Cancer Signs & S…
216 viewsMar 30, 2023
YouTubeLet's Talk About LGSOC
What Is VeriSM—and Is It the Next Generation of ITSM?
Sep 30, 2019
helixops.ai
VERITAC-2: a Phase III study of vepdegestrant, a PROTAC ER deg…
Jun 27, 2024
nih.gov
7:49
AVMAPKI FAKZYNJA CO-PACK - FDA NDA approval - 2025-05-08
186 views9 months ago
YouTubeInside Drug Discovery
See more videos
Static thumbnail place holder